Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
CPIX
CPIX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CPIX News
Cumberland Pharmaceuticals Receives FDA Fast Track Designation
Feb 04 2026
PRnewswire
Cumberland Receives FDA Fast Track Designation for DMD Therapy
Feb 04 2026
Newsfilter
Key Research Insights on NVIDIA, Netflix, and Merck
Dec 19 2025
NASDAQ.COM
Zacks Begins Coverage of CPIX with a Positive Outlook
Dec 19 2025
NASDAQ.COM
Cumberland Pharmaceuticals Launches J-Code for Caldolor Injection, Enhancing Non-Opioid Pain Management
Dec 08 2025
PRnewswire
Cumberland Pharmaceuticals Links Caldolor Injection to J-Code J1741, Enhancing Non-Opioid Pain Management
Dec 08 2025
Newsfilter
Medtech Stocks Surge in After-Hours Trading: RxSight, Penumbra, and Evolus Take the Lead
Nov 06 2025
NASDAQ.COM
Cumberland announces product expansion and reports $8.3M in Q3 revenue while progressing clinical pipeline
Nov 04 2025
SeekingAlpha
CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH
Nov 04 2025
PRnewswire
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE
Oct 28 2025
PRnewswire
RedHill's Talicia® Obtains $4 Million Strategic Investment and U.S. Co-Commercialization Agreement
Oct 20 2025
Newsfilter
CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO
Oct 20 2025
PRnewswire
RedHill's Talicia® Secures $4 Million Strategic Investment and U.S. Co-Commercialization Partnership Deal
Oct 20 2025
PRnewswire
CUMBERLAND PHARMACEUTICALS' VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC.
Oct 13 2025
PRnewswire
CUMBERLAND PHARMACEUTICALS ANNOUNCES PRODUCT APPROVAL IN MEXICO
Oct 01 2025
PRnewswire
TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA
Sep 29 2025
PRnewswire
Show More News
